Document Detail


Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones.
MedLine Citation:
PMID:  15133333     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We evaluated the effect of nifedipine associated with prednisolone in ureteral stone passage. MATERIAL AND METHODS: In our department we enrolled 50 patients with radiopaque ureteral stones. Stone size was 15 mm or less. The patients were divided into two groups: group I included 25 patients who received 30 mg oral treatment of slow-release nifedipine (for a maximum of 20 days) and 25 mg of prednisolone (for a maximum of 10 days) daily. Group II was made up of 25 patients who received 25 mg of prednisolone daily. On request, both groups could use non-steroidal anti-inflammatory drugs. RESULTS: The mean expulsion time was 6 days in group I and 10 days in group II. The average stone size was 12 mm in group I and 12.8 mm in group II. Six patients suspended therapy in group I (5 erythema, 1 stomachache), and seven in group II (3 because of intolerable pain, 4 stomachache). The expulsion success rates were 68% in group I and 81% in group II. CONCLUSIONS: For ureteral stones that do not cause an emergency situation, such as obstructive uropathy, infection or intolerable pain, we suggest expulsive medical treatment with nifedipine and prednisolone, if there are no contraindications to drug use.
Authors:
A Saita; A Bonaccorsi; F Marchese; S V Condorelli; M Motta
Related Documents :
18270943 - Transureteral lithotripsy versus extracorporeal shock wave lithotripsy in management of...
465983 - Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium st...
23390733 - 401(k) plan asset allocation, account balances, and loan activity in 2011.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Urologia internationalis     Volume:  72 Suppl 1     ISSN:  0042-1138     ISO Abbreviation:  Urol. Int.     Publication Date:  2004  
Date Detail:
Created Date:  2004-05-10     Completed Date:  2004-08-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0417373     Medline TA:  Urol Int     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  43-5     Citation Subset:  IM    
Copyright Information:
Copyright 2004 S. Karger AG, Basel
Affiliation:
University of Catania, Clinica Urologica II, Catania, Catania, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Delayed-Action Preparations / administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Male
Nifedipine / administration & dosage*
Prednisolone / administration & dosage*
Prospective Studies
Risk Assessment
Severity of Illness Index
Treatment Outcome
Ureteral Calculi / drug therapy*,  radiography
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 21829-25-4/Nifedipine; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lithiasic obstructive uropathy. Hydronephrosis characterization by magnetic resonance pyelography.
Next Document:  ESWL: Comparing two analgesic techniques. Our experience.